7-30600040-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_002047.4(GARS1):c.418A>G(p.Ile140Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,609,710 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.418A>G | p.Ile140Val | missense_variant | Exon 3 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
GARS1 | ENST00000675651.1 | c.418A>G | p.Ile140Val | missense_variant | Exon 3 of 17 | ENSP00000502513.1 | ||||
GARS1 | ENST00000675810.1 | c.316A>G | p.Ile106Val | missense_variant | Exon 2 of 16 | ENSP00000502743.1 | ||||
GARS1 | ENST00000675693.1 | c.250A>G | p.Ile84Val | missense_variant | Exon 4 of 18 | ENSP00000502174.1 | ||||
GARS1 | ENST00000675051.1 | c.217A>G | p.Ile73Val | missense_variant | Exon 3 of 17 | ENSP00000502296.1 | ||||
GARS1 | ENST00000674815.1 | c.49A>G | p.Ile17Val | missense_variant | Exon 3 of 17 | ENSP00000502799.1 | ||||
GARS1 | ENST00000674851.1 | c.49A>G | p.Ile17Val | missense_variant | Exon 4 of 18 | ENSP00000502451.1 | ||||
GARS1 | ENST00000444666.6 | n.418A>G | non_coding_transcript_exon_variant | Exon 3 of 18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*132A>G | non_coding_transcript_exon_variant | Exon 4 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.418A>G | non_coding_transcript_exon_variant | Exon 3 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.418A>G | non_coding_transcript_exon_variant | Exon 3 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.418A>G | non_coding_transcript_exon_variant | Exon 3 of 16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*288A>G | non_coding_transcript_exon_variant | Exon 4 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.418A>G | non_coding_transcript_exon_variant | Exon 3 of 15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*288A>G | non_coding_transcript_exon_variant | Exon 4 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.418A>G | non_coding_transcript_exon_variant | Exon 3 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.418A>G | non_coding_transcript_exon_variant | Exon 3 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.418A>G | non_coding_transcript_exon_variant | Exon 3 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.418A>G | non_coding_transcript_exon_variant | Exon 3 of 17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.418A>G | non_coding_transcript_exon_variant | Exon 3 of 16 | ENSP00000502681.1 | |||||
GARS1 | ENST00000674616.1 | n.*132A>G | 3_prime_UTR_variant | Exon 4 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000675529.1 | n.*288A>G | 3_prime_UTR_variant | Exon 4 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000676088.1 | n.*288A>G | 3_prime_UTR_variant | Exon 4 of 19 | ENSP00000501884.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000801 AC: 2AN: 249534Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135380
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1457510Hom.: 0 Cov.: 29 AF XY: 0.00000276 AC XY: 2AN XY: 725420
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74338
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Uncertain:1
This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 140 of the GARS protein (p.Ile140Val). This variant is present in population databases (no rsID available, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with GARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 1952437). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt GARS protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at